Product Information
LOSARTAN POTASSIUM 50 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0324 per EA under NDC 68382013610. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 6, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Losartan Potassium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382013610
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078243FDA Approved
10/6/2010
TE Code
AB
On Market Since
10/4/2010
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN POTASSIUM 50 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 53.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0324 per EA |
|---|---|
| All-time high | $0.1233 (Sep 16, 2020) |
| All-time low | $0.0304 (Nov 19, 2025) |
| 52-week high | $0.0343 |
| 52-week low | $0.0304 |
| Median price | $0.0489 |
| Average price | $0.0556 |
| Largest weekly change | +29.7% (Aug 21, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOSARTAN POTASSIUM 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN POTASSIUM 50 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0324 per EA (NDC 68382013610), effective Aug 19, 2026.
How has the price of LOSARTAN POTASSIUM 50 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN POTASSIUM 50 MG TAB has declined 53.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOSARTAN POTASSIUM 50 MG TAB?
Since Nov 28, 2013, the NADAC for LOSARTAN POTASSIUM 50 MG TAB has ranged from a low of $0.0304 (Nov 19, 2025) to a high of $0.1233 (Sep 16, 2020), with a median of $0.0489 per EA.
Are there cheaper alternatives to LOSARTAN POTASSIUM 50 MG TAB?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN POTASSIUM 50 MG TAB, is $0.0315 per EA — about 3% below LOSARTAN POTASSIUM 50 MG TAB.
Who manufactures LOSARTAN POTASSIUM 50 MG TAB?
LOSARTAN POTASSIUM 50 MG TAB (NDC 68382013610) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.